MYRIAD GENETICS, INC. Other Cost of Operating Revenue
MYRIAD GENETICS, INC. (MYGN) reported Other Cost of Operating Revenue of $2.07 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherCostOfOperatingRevenue · last filed 2014-11-05
- MYRIAD GENETICS, INC. other cost of operating revenue for the quarter ending 2014-09-30 was $2.07M, a 48.84% decline year-over-year.
- MYRIAD GENETICS, INC. other cost of operating revenue for the quarter ending 2014-06-30 was $2.68M, a 26.66% decline year-over-year.
- MYRIAD GENETICS, INC. other cost of operating revenue for the quarter ending 2014-03-31 was $2.96M, a 23.53% decline year-over-year.
- MYRIAD GENETICS, INC. other cost of operating revenue for the quarter ending 2013-12-31 was $3.38M, a 21.82% decline year-over-year.
- MYRIAD GENETICS, INC. other cost of operating revenue for fiscal 2014 was $13.06M, a 14.31% decline from fiscal 2013.
- MYRIAD GENETICS, INC. other cost of operating revenue for fiscal 2013 was $15.24M, a 15.41% increase from fiscal 2012.
- MYRIAD GENETICS, INC. other cost of operating revenue for fiscal 2012 was $13.21M, a 1126.28% increase from fiscal 2011.
- MYRIAD GENETICS, INC. other cost of operating revenue for fiscal 2011 was $1.08M.
| Period end | Other Cost of Operating Revenue 3 month | Other Cost of Operating Revenue 6 month | Other Cost of Operating Revenue 9 month | Other Cost of Operating Revenue 12 month |
|---|---|---|---|---|
| 2014-09-30 | $2.07M 10-Q · filed 2014-11-05 | $4.75M derived: sum of 2 quarters · filed 2014-11-05 | $7.71M derived: sum of 3 quarters · filed 2014-11-05 | $11.09M derived: sum of 4 quarters · filed 2014-11-05 |
| 2014-06-30 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $5.64M derived: sum of 2 quarters · filed 2014-08-13 | $9.02M derived: sum of 3 quarters · filed 2014-08-13 | $13.06M 10-K · filed 2014-08-13 |
| 2014-03-31 | $2.96M 10-Q · filed 2014-05-07 | $6.34M derived: sum of 2 quarters · filed 2014-05-07 | $10.38M 10-Q · filed 2014-05-07 | $14.04M derived: sum of 4 quarters · filed 2014-11-05 |
| 2013-12-31 | $3.38M 10-Q · filed 2014-02-05 | $7.42M 10-Q · filed 2014-02-05 | $11.07M derived: sum of 3 quarters · filed 2014-11-05 | $14.95M derived: sum of 4 quarters · filed 2014-11-05 |
| 2013-09-30 | $4.04M 10-Q · filed 2014-11-05 | $7.70M derived: sum of 2 quarters · filed 2014-11-05 | $11.57M derived: sum of 3 quarters · filed 2014-11-05 | $15.89M derived: sum of 4 quarters · filed 2014-11-05 |
| 2013-06-30 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $7.53M derived: sum of 2 quarters · filed 2014-08-13 | $11.85M derived: sum of 3 quarters · filed 2014-08-13 | $15.24M 10-K · filed 2014-08-13 |
| 2013-03-31 | $3.87M 10-Q · filed 2014-05-07 | $8.19M derived: sum of 2 quarters · filed 2014-05-07 | $11.59M 10-Q · filed 2014-05-07 | $14.66M derived: sum of 4 quarters · filed 2014-08-13 |
| 2012-12-31 | $4.32M 10-Q · filed 2014-02-05 | $7.71M 10-Q · filed 2014-02-05 | $10.79M derived: sum of 3 quarters · filed 2014-08-13 | $14.56M derived: sum of 4 quarters · filed 2014-08-13 |
| 2012-09-30 | $3.40M 10-Q · filed 2013-11-12 | $6.47M derived: sum of 2 quarters · filed 2014-08-13 | $10.24M derived: sum of 3 quarters · filed 2014-08-13 | $13.54M derived: sum of 4 quarters · filed 2014-08-13 |
| 2012-06-30 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $6.84M derived: sum of 2 quarters · filed 2014-08-13 | $10.14M derived: sum of 3 quarters · filed 2014-08-13 | $13.21M 10-K · filed 2014-08-13 |
| 2012-03-31 | $3.76M 10-Q · filed 2013-05-08 | $7.07M derived: sum of 2 quarters · filed 2013-05-08 | $10.13M 10-Q · filed 2013-05-08 | |
| 2011-12-31 | $3.30M 10-Q · filed 2013-02-06 | $6.36M 10-Q · filed 2013-02-06 | ||
| 2011-09-30 | $3.06M 10-Q · filed 2012-11-09 | |||
| 2011-06-30 | $1.08M 10-K · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |